Evaluation of lipid disorders and hyperglycemia in an open population aged 30-69 years: results of a multicenter study

Aim. To identify lipid metabolism disorders and hyperglycemia in the open population aged 30-69 in 5 cities of the Vladimir region, taking into account sex characteristics.

Material and methods. The study included 1350 people (men and women aged 30-69 years), while 1174 people completed the study; the response rate was 87%. There were 424 (36,1%) men and 750 (63,9%) women among those completed the study. All participants were interviewed according to a standard questionnaire, including questions on socio-demographic status, behavioral and biological risk factors for cardiovascular diseases, as well as the presence of somatic diseases and their treatment. The blood concentrations of total cholesterol (TC), triglycerides, high-density lipoprotein (HDL) cholesterol and glucose were determined.

Results. The average indicators of TC in the adult population were 5,28±0,75 mmol/l, for men and women its level was comparable. Sex differences were revealed in the average blood level of HDL-C. In the male population, its level was 1±0,11 mmol/l, and among women it was 1,14±0,14 mmol/l (p<0,001). The blood concentration of triglycerides was significantly higher compared to women — 1,8 [1,5; 2,1] mmol/l in men vs 1,7 [1,3; 2,0] mmol/l in women (p<0,035). In the examined adult population, 56,7% had an elevated TC level, while the prevalence of hypercholesterolemia among men and women was comparable — 57,8 and 55,7%, respectively. Hyperglycemia was found in 22% of all examined, while among men it was detected in every fourth, and among women in every fifth. Sex differences were significant (p=0,045). The prevalence of prediabetes among men is significantly higher compared to women — 17,2 and 11,9% (p=0,013), while the prevalence of diabetes in men and women was comparable — 7,3 and 7,6%, respectively.

Conclusion. Every second participant among men and women of the Vladimir region population has hypercholesterolemia, while fasting hyperglycemia is detected in every fourth man and fifth woman. Among men, the incidence of prediabetes is 2,5 times, and among women 1,5 times higher than the prevalence of diabetes. Thus, deve­lopment of preventive interventions in a particular region of the Central Federal District should take into account the high prevalence of hyper­cholesterolemia and hyperglycemia, including early disorders of car­bohydrate metabolism.

1. Roth GA, Mensah GA, Johnson CO, et al. GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. doi:10.1016/j.jacc.2020.11.010.

2. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Preven­tion of chronic non-communicable diseases in the Russian Fede­ration. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728-8800-2022-3235.

3. Mangione CM, Barry MJ, Nicholson WK, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;328(8):746-53. doi:10.1001/jama.2022.13044.

4. Reiner Ž. Hypertriglyceridaemia and risk of coronary artery di­sease. Nat Rev Cardiol. 2017;14(7):401-11. doi:10.1038/nrcardio.2017.31.

5. Casula M, Colpani O, Xie S, et al. HDL in Atherosclerotic Cardio­vascular Disease: In Search of a Role. Cells. 2021;10(8):1869. doi:10.3390/cells10081869.

6. Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines "Management of obesity ant its comorbidities". Obesity and metabolism. 2021;18(1):5-99. (In Russ.) doi:10.14341/omet12714.

7. Einarson TR, Acs A, Ludwig C, et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol. 2018;17(1):83. doi:10.1186/s12933-018-0728-6.

8. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association. Circulation. 2022;145(8):e153-e639. doi:10.1161/CIR.0000000000001052.

9. He J, Zhu Z, Bundy JD, et al. Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018. JAMA. 2021;326(13):1286-98. doi:10.1001/jama.2021.15187.

10. Mamedov MN, Yevdokimova AA, Tokareva ZN, et al. Prevalence of cardiovascular risk factors in a random sample of Russian men and women. International Heart and Vascular Disease Journal. 2013;1:52-60. (In Russ.) doi:10.24412/2311-1623-2013-1-52-60.

11. Metelskaya VA, Shalnova SA, Deev AD, et al. Analysis of athero­genic dyslipidemias prevalence among population of Russian Federation (results of the ESSE-RF Study). Profilakticheskaya Meditsina. 2016;19(1):15-23. (In Russ.) doi:10.17116/profmed201619115-23.

12. Chmelík Z, Vaclová M, Lánská V, et al. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic. Cent Eur J Public Health. 2020;28(2):114-9. doi:10.21101/cejph.a5730.

13. Pająk A, Szafraniec K, Polak M, et al. Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn. 2016;126(9):642652. doi:10.20452/pamw.3464.

14. Cheng YJ, Kanaya AM, Araneta MRG, et al. Prevalence of Dia­betes by Race and Ethnicity in the United States, 2011-2016. JAMA. 2019;322(24):2389-98. doi:10.1001/jama.2019.19365.

15. Shestakova EA, Lunina EY, Galstyan GR, et al. Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION study. Diabetes Mellitus. 2020;23(1):4-11. (In Russ.) doi:10.14341/DM12286.